Cgi Ophthalmic Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-05-2024
- Paid Up Capital ₹ 0.50 M
as on 30-05-2024
- Company Age 35 Year, 3 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.00 Cr
as on 30-05-2024
- Satisfied Charges ₹ 42.86 Cr
as on 30-05-2024
- Revenue 11.15%
(FY 2021)
- Profit 114.06%
(FY 2021)
- Ebitda 106.05%
(FY 2021)
- Net Worth 39.88%
(FY 2021)
- Total Assets -15.18%
(FY 2021)
About Cgi Ophthalmic
The Corporate was formerly known as Rare Herbs Pvt Ltd. The Company is engaged in the Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹30.00 Cr. The company has closed loans amounting to ₹42.86 Cr, as per Ministry of Corporate Affairs (MCA) records.
Purnima Dave and Jagrat Dave serve as directors at the Company.
- CIN/LLPIN
U36912GJ1989PTC013127
- Company No.
013127
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cgi Ophthalmic?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Purnima Dave  | Director | 25-Jun-2008 | Current |
| Jagrat Dave | Director | 05-Jul-2000 | Current |
Financial Performance and Corporate Structure Insights of Cgi Ophthalmic.
Cgi Ophthalmic Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 11.15% increase. The company also saw a substantial improvement in profitability, with a 114.06% increase in profit. The company's net worth Soared by an impressive increase of 39.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cgi Ophthalmic?
In 2021, Cgi Ophthalmic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Care4sight Pharma Private LimitedActive 5 years 1 monthPurnima Dave and Jagrat Dave are mutual person
- Caregroup Sight Solution Private LimitedActive 4 years 11 months
Purnima Dave and Jagrat Dave are mutual person
Contacare Opthalmic Private LimitedActive 27 years 7 monthsPurnima Dave and Jagrat Dave are mutual person
- Intra Ocular Care Private LimitedActive 35 years 14 days
Purnima Dave and Jagrat Dave are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Jan 2021 | ₹30.00 Cr | Open |
Others Creation Date: 08 Mar 2019 | ₹25.00 Cr | Satisfied |
Others Creation Date: 08 Mar 2019 | ₹1.80 Cr | Satisfied |
How Many Employees Work at Cgi Ophthalmic?
Unlock and access historical data on people associated with Cgi Ophthalmic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cgi Ophthalmic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cgi Ophthalmic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
